Gert O. De Meerleer

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications

Overall Survival After Hormones and Radiotherapy Postprostatectomy: Relevant End Point or Overrated?

Overall Survival After Hormones and Radiotherapy Postprostatectomy: Relevant End Point or Overrated?

Journal: European urology
Published: July 23, 2026

Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease.

Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease.

Journal: Nature reviews. Urology
Published: March 31, 2026

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

Journal: European urology
Published: March 25, 2026

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

Journal: European urology
Published: March 25, 2026

Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis.

Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis.

Journal: Acta oncologica (Stockholm, Sweden)
Published: January 26, 2026

Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Naïve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node-Positive Prostate Cancer.

Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Naïve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node-Positive Prostate Cancer.

Journal: Advances in radiation oncology
Published: October 14, 2025

Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).

Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).

Journal: European urology oncology
Published: September 29, 2025

Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort.

Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort.

Journal: European urology open science
Published: July 14, 2025

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy.

Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapy.

Journal: Health and quality of life outcomes
Published: May 26, 2025

Moderately hypofractionated radiotherapy for prostate cancer in an era of SBRT and focal boosting.

Moderately hypofractionated radiotherapy for prostate cancer in an era of SBRT and focal boosting.

Journal: The Lancet. Oncology
Published: February 06, 2025

Direct Treatment of All Visible Tumour in Synchronous Oligometastatic Prostate Cancer: Total Eradication of Tumour or the Full Monty Treatment.

Direct Treatment of All Visible Tumour in Synchronous Oligometastatic Prostate Cancer: Total Eradication of Tumour or the Full Monty Treatment.

Journal: European urology oncology
Published: February 02, 2025

Stereotactic Body Radiation Therapy Alone or in Combination with Immunotherapy in Kidney Cancer: A Systematic Review.

Stereotactic Body Radiation Therapy Alone or in Combination with Immunotherapy in Kidney Cancer: A Systematic Review.

Journal: European urology
Published: December 02, 2024
Showing 1-12 of 150

Last Updated: 09/26/2026